These data suggested that the CCL5-CCR1, SELPLG-SELL, CXCL10-CXCR3, and CXCL9-CXCR3 ligand-receptor pairs were likely to be the key interactions between immune cells in the melanoma tumor microenvironment. The gene discussed is SELL; the disease is neoplasm.